Details of the Drug

General Information of Drug (ID: DMZ8AOC)

• Drug Name: JNJ-81201887
• Synonyms: JNJ-1887?

Indication

Disease Entry	ICD 11	Status	REF
Macular degeneration	9B78.3	Phase 2	[1]

• Cross-matching ID: TTD ID: DJ1L4K

References

• [1] ClinicalTrials.gov (NCT05811351) A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD). U.S.National Institutes of Health.